GLS and colorectal carcinoma: In addition, the overexpression of YTHDF1 notably enhances cisplatin resistance in cisplatin‐resistant CRC cells (LoVo CDDP R) and in vivo xenograft mouse models by upregulating GLS1‐induced Gln metabolism.